Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus Associated with Hospitalized Newborn Infants

Area of Science:

• Microbiology
• Infectious Diseases
• Genomics

Background:

• Multidrug resistance (MDR) in healthcare settings poses a significant challenge.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections.
• Neonatal intensive care units are particularly vulnerable to MDR pathogen outbreaks.

Purpose of the Study:

• To investigate the characteristics of hospital-associated MDR-MRSA strains isolated from newborn infants.
• To determine the antimicrobial resistance profiles, virulence factors, and genetic makeup of these strains.
• To identify potential sources and transmission routes of MDR-MRSA in neonatal populations.

Main Methods:

• Phenotypic and genotypic analyses were performed on five MDR-MRSA isolates.
• Whole genome sequencing (WGS) was utilized to identify antimicrobial resistance genes and genetic elements.
• Analysis included antimicrobial susceptibility testing, slime and biofilm formation assays, SCCmec typing, spa typing, and virulence gene profiling.

Main Results:

• All five MDR-MRSA strains produced slime and biofilms and harbored SCCmec type IV.
• Antimicrobial resistance varied, with one strain resistant to seven classes of antibiotics.
• WGS revealed that most antimicrobial resistance genes were chromosomally located, with one plasmid-borne gene (ermC).

Conclusions:

• The presence of MDR-MRSA in neonates is a serious public health concern.
• Multifaceted interventions are crucial to control the spread of these resistant strains.
• Improved metadata collection is essential for future antimicrobial resistance investigations.